Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Minocycline in Multi-System-Atrophy (MSA)
NCT00146809Phase 3Completed
- Sponsor
- German Parkinson Study Group
- Start
- Dec 2003
- Modality
- Small Molecules
- Countries
- 2
01
Overview
Phase 3, randomised, double-blind trial in multiple system atrophy (MSA) comparing Minocycline with Placebo (2 arms). Primary endpoint: Unified Multiple System Atrophy Rating Scale Part II at 48 weeks. Started Dec 2003; status: completed.
02
Drugs
minocycline
03
Conditions
multiple system atrophy (MSA)
Beyond the preview
Go deeper on NCT00146809.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT00146809.